dacarbazine has been researched along with Weight Loss in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abasq, C; Charles-Pétillon, F; Coat, C; De Braekeleer, M; Marcorelles, P; Quintin-Roué, I; Talagas, M; Uguen, A | 1 |
el Omri, H; Ennabli, S; Korbi, S; Kraiem, I; Skouri, H; Sriha, B; Youssef, YB | 1 |
2 other study(ies) available for dacarbazine and Weight Loss
Article | Year |
---|---|
[A silent-growing and fast-killing melanoma in a teenager].
Topics: Adolescent; Antibodies, Monoclonal; Antineoplastic Agents, Alkylating; Back Pain; Combined Modality Therapy; Cyclin D1; Dacarbazine; Drug Resistance, Neoplasm; Fatal Outcome; Female; Gene Amplification; Head and Neck Neoplasms; Humans; Immunotherapy; In Situ Hybridization, Fluorescence; Ipilimumab; Lymphatic Metastasis; Melanoma; Nausea; Neoplasm Proteins; Neoplasms, Second Primary; Nevus; Osteolysis; Scalp; Skin Neoplasms; Weight Loss | 2012 |
[Gastric adenocarcinoma secondary to Hodgkin's disease treatment].
Topics: Adenocarcinoma; Adult; Aftercare; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Dacarbazine; Deglutition Disorders; Doxorubicin; Fatal Outcome; Hodgkin Disease; Humans; Male; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Radiotherapy, Adjuvant; Stomach Neoplasms; Tomography, X-Ray Computed; Vinblastine; Weight Loss | 2001 |